Advance of promising targets and agents against 2019-nCoV in China

18 March 2020
Download Type: Adobe PDF

Considering the seriousness and suddenness of the COVID-19 outbreak, ~200 clinical trials on COVID-19 have commenced in China, and it is promising to report that certain targets and their agents have displayed strong antiviral potential, of which some have been permitted to be used in an attempt to combat the disease in clinical trials.